Godavari Biorefineries
GODAVARIB NSE
Godavari Biorefineries
FMCGNSE: GODAVARIB BSE: 544279 Diversified FMCG
Key Fundamentals
MicrocapDiversified FMCGFMCGMarket Cap
₹1,196 Cr
Volatility
Moderate
P/E Ratio
7,788.33
EBITDA
₹95.98 Cr
Return on Equity
-2.99%
Debt to Equity
0.67
Book Value
₹154.03
52W High
₹353
52W Low
₹227.42
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Debtor days have improved from 29.6 to 20.9 days.
Weaknesses
3- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 5.26% over past five years.
- Company has a low return on equity of 1.13% over last 3 years.
Growth Rate
Revenue Growth
5.35% higher than
3Y
Net Income Growth
-117% lower than
3Y
Cash Flow Change
-96.68% higher than
3Y
ROE
-222% lower than
3Y
ROCE
-34.27% higher than
3Y
EBITDA Margin (Avg.)
-24.76% higher than
3Y
Quarterly Results
| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 239 | 398 | 615 | 523 | 321 | 447 | 580 | 533 | 431 | 460 | 564 | 558 |
| Expenses | 271 | 353 | 501 | 535 | 354 | 411 | 467 | 527 | 439 | 417 | 478 | 557 |
| Operating Profit | -32 | 45 | 114 | -12 | -33 | 36 | 112 | 6 | -8 | 43 | 86 | 1 |
| OPM % | -13% | 11% | 18% | -2.3% | -10% | 8% | 19% | 1.1% | -1.8% | 9% | 15% | 0.1% |
| Other Income | 1 | 2 | 11 | 3 | 1 | 4 | 9 | 1 | -23 | -6 | 9 | 2 |
| Interest | 20 | 18 | 20 | 20 | 20 | 19 | 13 | 15 | 12 | 10 | 11 | 14 |
| Depreciation | 15 | 16 | 14 | 13 | 12 | 12 | 13 | 14 | 14 | 14 | 14 | 14 |
| PBT | -65 | 13 | 91 | -42 | -64 | 8 | 96 | -22 | -57 | 13 | 70 | -26 |
| Tax % | 0% | -201% | 28% | -37% | 17% | 32% | 25% | -28% | -27% | 39% | 25% | -25% |
| Net Profit | -65 | 38 | 65 | -26 | -75 | 6 | 72 | -16 | -42 | 8 | 53 | -19 |
| EPS in Rs | -15.53 | 9.16 | 15.54 | -6.23 | -17.88 | 1.13 | 14.06 | -3.13 | -8.13 | 1.61 | 10.33 | -3.78 |
Profit & Loss
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,459 | 1,538 | 1,702 | 2,015 | 1,687 | 1,870 | 1,988 | 2,013 |
| Expenses | 1,356 | 1,381 | 1,568 | 1,867 | 1,553 | 1,766 | 1,861 | 1,891 |
| Operating Profit | 103 | 158 | 134 | 147 | 134 | 104 | 127 | 122 |
| OPM % | 7% | 10% | 8% | 7% | 8% | 6% | 6% | 6% |
| Other Income | 14 | 8 | 6 | 7 | 14 | 16 | -19 | -18 |
| Interest | 69 | 72 | 60 | 73 | 76 | 72 | 49 | 48 |
| Depreciation | 45 | 47 | 48 | 50 | 60 | 50 | 54 | 55 |
| PBT | 3 | 46 | 32 | 32 | 12 | -2 | 5 | 1 |
| Tax % | -24% | 41% | 40% | 38% | 1% | 1421% | 23% | — |
| Net Profit | 4 | 27 | 19 | 20 | 12 | -23 | 4 | 0 |
| EPS in Rs | 0.97 | 6.47 | 4.55 | 4.68 | 2.93 | -4.57 | 0.69 | 0.03 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 42 | 42 | 42 | 42 | 42 | 51 | 51 |
| Reserves | 385 | 412 | 431 | 448 | 459 | 731 | 737 |
| Borrowings | 589 | 569 | 636 | 736 | 655 | 490 | 531 |
| Other Liabilities | 418 | 419 | 625 | 518 | 836 | 683 | 733 |
| Total Liabilities | 1,434 | 1,442 | 1,734 | 1,744 | 1,992 | 1,955 | 2,052 |
| Fixed Assets | 735 | 708 | 667 | 866 | 850 | 862 | 885 |
| CWIP | 17 | 9 | 50 | 17 | 29 | 37 | 129 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 683 | 725 | 1,016 | 860 | 1,113 | 1,055 | 1,038 |
| Total Assets | 1,434 | 1,442 | 1,734 | 1,744 | 1,992 | 1,955 | 2,052 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 250 | 130 | 45 | 197 | 185 | 6 | 171 |
| Investing | -23 | -7 | -48 | -214 | -44 | -69 | -163 |
| Financing | -226 | -121 | 6 | 28 | -151 | 64 | -6 |
| Net Cash Flow | 1 | 2 | 3 | 11 | -10 | 1 | 3 |
| Free Cash Flow | 223 | 119 | -5 | -20 | 130 | -65 | 6 |
| CFO/OP | 242 | 82 | 34 | 135 | 140 | 6 | 136 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 31 | 40 | 37 | 37 | 41 | 27 | 21 |
| Inventory Days | 130 | 146 | 200 | 137 | 250 | 195 | 198 |
| Days Payable | 123 | 132 | 176 | 105 | 195 | 140 | 146 |
| Cash Conversion Cycle | 39 | 55 | 61 | 68 | 95 | 82 | 74 |
| Working Capital Days | -68 | 1 | 3 | 2 | -14 | 21 | 16 |
| ROCE % | — | 12% | 9% | 9% | 7% | 6% | 7% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Godavari Biorefineries insights
59 extracted metrics + investor summaries across FY18–FY27.
Documents
1
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
30 Apr - Company states SEBI large-corporate debt framework is not applicable. 30 Apr - Company states SEBI large-corporate debt framework is not applicable.
2
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
30 Apr - Company states SEBI large-corporate debt framework is not applicable. 30 Apr - Company states SEBI large-corporate debt framework is not applicable.
3
Announcement under Regulation 30 (LODR)-Newspaper Publication
23 Apr - Window to re-lodgement of transfer request of physical shares 23 Apr - Window to re-lodgement of transfer request of physical shares
4
Announcement under Regulation 30 (LODR)-Newspaper Publication
13h - Window to re-lodgement of transfer request of physical shares 13h - Window to re-lodgement of transfer request of physical shares
5
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
14 Apr - Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2028 for the quarter 31st March, 2026 14 Apr - Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2028 for the quarter 31st March, 2026
Frequently Asked Questions about Godavari Biorefineries
What does Godavari Biorefineries Ltd do?
Incorporated in 1939, Godavari Biorefineries Ltd is a manufacturer of Bio-based Chemicals and Ethanol[1]
Where is Godavari Biorefineries Ltd (GODAVARIB) listed?
Godavari Biorefineries Ltd trades as GODAVARIB on the NSE and under code 544279 on the BSE.
Which sector does Godavari Biorefineries Ltd belong to?
Godavari Biorefineries Ltd is classified under the FMCG sector, in the Diversified FMCG industry.
What is the market capitalisation of Godavari Biorefineries Ltd?
Godavari Biorefineries Ltd has a market capitalisation of ₹1,196 Cr, which places it in the Small Cap band.
What is the PE ratio of Godavari Biorefineries Ltd?
Godavari Biorefineries Ltd trades at a PE ratio of 7788.33, against a book value of ₹154.03 per share.
What is the 52-week high and low of Godavari Biorefineries Ltd?
Over the last 52 weeks Godavari Biorefineries Ltd has traded between ₹227.42 and ₹353.
What is the Return on Equity (ROE) of Godavari Biorefineries Ltd?
Godavari Biorefineries Ltd reported a return on equity of -2.99%. Its debt-to-equity ratio is 0.67.
Company Information
Incorporated in 1939, Godavari Biorefineries Ltd is a manufacturer of Bio-based Chemicals and Ethanol[1]
Website godavaribiorefineries.com
CEO Mr. Samir Shantilal Somaiya
Employees 1,692
Listed 2024-10-30
Face Value ₹ 10
Issued Size 5,11,75,977
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/GODAVARIB.md for Godavari Biorefineries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.